3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Extracorporeal Membrane Oxygenation – Crucial Considerations during the Coronavirus Crisis

      editorial
      , MD, FASE, FAHA *
      Journal of Cardiothoracic and Vascular Anesthesia
      Elsevier Inc.
      Extracorporeal membrane oxygenation, Personnel, Equipment, Facilities, Support systems

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction The illness due to severe acute respiratory syndrome-related coronavirus-2 commenced in December 2019 and is now a worldwide crisis. 1 , 2 Although patients with this infection may have mild-to-moderate disease with clinical recovery, some may develop severe respiratory failure with or without cardiovascular collapse. 3 , 4 The high risks of infection have mandated rigorous infectious precautions and adjusted workflows for patient care, including airway management, echocardiography, cardiothoracic and vascular procedures as well as extracorporeal membrane oxygenation (ECMO).5, 6, 7, 8, 9, 10, 11 The purpose of this freestanding editorial is to highlight the considerations in ECMO for critically ill patients with this important disease. The Extracorporeal Life Support Organization has recently released a guideline to outline strategies for this mechanical therapy in this setting. 5 This clinical focus will include best practices to disseminate the highest standards for care of both our patients and ourselves during this crisis. The provided references can also serve as a guide for healthcare teams as they manage the demands of the pandemic at their respective institutions. Consider the Key Components and Indications for ECMO The key components for the planning and provision of ECMO services in this pandemic include the following considerations: personnel, equipment, facilities, and support systems.11, 12, 13, 14, 15, 16 Although ECMO has been recommended by the World Health Organization in settings with access to this expertise at experienced centers, current guidelines from the Extracorporeal Life Support Organization further emphasize that ECMO should primarily be considered as a supportive modality in experienced centers.12, 13, 14, 15, 16 Furthermore, an additional key consideration is that ECMO is a rescue strategy for severe adult respiratory distress syndrome. 5 The initial management priorities in this challenging scenario include treating the underlying cause, securing the airway, optimizing protective low-stretch lung ventilation, as well as judicious fluid therapy and titrated diuresis. 5 , 14 In the setting of these management approaches, oxygenation may still deteriorate as measured by decreases in the blood oxygen tension/inspired oxygen ratio. 14 , 15 When this ration falls below 150 mmHg, further recommended interventions include recruitment maneuvers, prone positioning, neuromuscular blockade, titration of positive end–expiratory pressure, and inhaled pulmonary vasodilators such as nitric oxide and epoprostenol. 5 If this ratio falls below 80 mmHg for 6 hours, or below 50 mmHg for 3 hours, then ECMO should be considered in the absence of institution-specific contraindications.12, 13, 14 A third recognized indication for ECMO in this setting has also been based on a deteriorating arterial blood gas, namely a pH below 7.25 with a blood carbon dioxide tension greater than 60 mmHg for at least 6 hours. 5 Although ECMO is the primary strategy for management of refractory hypercarbia in this clinical setting, extracorporeal carbon dioxide removal may have a role in highly selected patients. 16 , 17 The contraindications for ECMO in patients with coronavirus virus infection must be hospital-specific, taking into account factors such as experience with ECMO and availability of resources in real-time during the pandemic. 12 , 14 Furthermore, patient comorbidities such as advanced age, frailty, chronic lung disease, diabetes, heart failure, and prolonged mechanical ventilation significantly increase mortality risk in severe coronavirus infection and may consequently be contraindications to ECMO. 14 , 16 The indications and contraindications to ECMO during the coronavirus crisis should be adjusted in real-time to local factors. Consider the Personnel In ECMO The assignment and management of personnel in the delivery of ECMO services at an experienced center should be centralized. 18 , 19 There should be a clear chain of command that can dynamically lead the ECMO service line through the pandemic landscape. 20 , 21 It is important to have flexible staffing models that maintain both the institutional standards and adequate reserves that can accommodate staff attrition. 12 , 14 Experienced centers may have to augment their relationships with referring centers with respect to advice, support, and transport protocols to accommodate the full impact of this pandemic, including the highly infectious nature of the coronavirus infection.1, 2, 3, 4 , 22 The ECMO personnel will all require site-specific intensive training for the unique considerations of active coronavirus infection. These unique considerations cover indications and contraindications for ECMO, infectious hygiene, full barrier precautions including personal protective equipment, as well as control of aerosolization during airway management, echocardiography and transport.5, 6, 7, 8, 9, 10, 11, 12 Patients may have to be grouped into cohorts for ECMO support in clearly designated hospital areas that are equipped and managed appropriately for maximal precautions.12, 13, 14 Consider the Equipment in ECMO The management of the ECMO equipment is essential to facilitate a smooth hardware process during the surge phase of the pandemic. 23 There should be a record of all equipment that can track hardware movement throughout the health system in real-time. This tracking and managing of hardware is best managed centrally with attention to reserves, changes in demand, control of waste, and avoiding of regional hoarding.12, 13, 14 In the setting of a mobile lung rescue service, this hardware should be added to the central registry, including mobile echocardiography.22, 23, 24 The availability of all hardware supplies could also be a combination of regular supplies and additional supplies specific for a patient with suspected or known coronavirus infection. The titration of clinical simulation can greatly enhance best practices for appropriate utilization of all these supplies across all team members and member institutions.12, 13, 14 Consider the Facilities The preparations and management of the ECMO service line during the coronavirus crisis should ideally be part of the coordinated response from the health system in question.25, 26 A flexible strategy to accommodate infected patients requiring ECMO support may require thoughtful development of bed capacity across the health system, including regional coalition with neighboring hospitals as needed. 25 These plans for bed capacity should also include resilient and synergistic approaches within and across centers to address clustering of cases, infection control, patient transport, and waste management.12, 13, 14 The ECMO teams should be protected and supported through the crisis with a dedicated leadership team, a focus on infection prevention, and an emphasis on high-quality open and transparent communication,25, 26 Consider the Support Systems The support systems for the delivery of high-quality ECMO services should focus on the dynamics of the personnel, hardware quality and supply, and the clinical space.25, 26 Key processes in this arena include communication, coordination, resource allocation, contingency planning and management, information tracking, quality assurance and focused research opportunities.12, 13, 14 Critical information should be transmitted in a timely and agile fashion to all team members via multiple platforms including team meetings, a telephone hotline, text-based messages, and e-mail groups. 25 The support of the health care team members and their families is an important component for successful navigation through the coronavirus crisis.25, 26, 27, 28 The negative psychological impact of quarantine can be considerable, including confusion, anger, and post-traumatic stress disorder.27, 28 The factors that can significantly increase the impact of quarantine on psychological wellbeing include stressors such as quarantine duration, levels of frustration and fear, boredom, perceived risks of infection, deficiencies in supplies and information, financial loss, and stigma. 28 The management of these stressors can mitigate to a large extent the negative psychological effects of quarantine for team members and their families who are navigating this process. Conclusions The current coronavirus crisis has challenged the delivery of high-acuity care worldwide, including the planning and provision of ECMO services. The delivery of the best care in ECMO for patients with coronavirus infection should ideally include consideration of the following factors in this challenging setting: indications, contraindications, personnel, equipment; health care facilities, and support systems. A sustained focus on infection control to prevent transmission of coronavirus remains essential during the conduct of ECMO in this pandemic.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

          Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

            Summary Background An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information about critically ill patients with SARS-CoV-2 infection is scarce. We aimed to describe the clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia. Methods In this single-centered, retrospective, observational study, we enrolled 52 critically ill adult patients with SARS-CoV-2 pneumonia who were admitted to the intensive care unit (ICU) of Wuhan Jin Yin-tan hospital (Wuhan, China) between late December, 2019, and Jan 26, 2020. Demographic data, symptoms, laboratory values, comorbidities, treatments, and clinical outcomes were all collected. Data were compared between survivors and non-survivors. The primary outcome was 28-day mortality, as of Feb 9, 2020. Secondary outcomes included incidence of SARS-CoV-2-related acute respiratory distress syndrome (ARDS) and the proportion of patients requiring mechanical ventilation. Findings Of 710 patients with SARS-CoV-2 pneumonia, 52 critically ill adult patients were included. The mean age of the 52 patients was 59·7 (SD 13·3) years, 35 (67%) were men, 21 (40%) had chronic illness, 51 (98%) had fever. 32 (61·5%) patients had died at 28 days, and the median duration from admission to the intensive care unit (ICU) to death was 7 (IQR 3–11) days for non-survivors. Compared with survivors, non-survivors were older (64·6 years [11·2] vs 51·9 years [12·9]), more likely to develop ARDS (26 [81%] patients vs 9 [45%] patients), and more likely to receive mechanical ventilation (30 [94%] patients vs 7 [35%] patients), either invasively or non-invasively. Most patients had organ function damage, including 35 (67%) with ARDS, 15 (29%) with acute kidney injury, 12 (23%) with cardiac injury, 15 (29%) with liver dysfunction, and one (2%) with pneumothorax. 37 (71%) patients required mechanical ventilation. Hospital-acquired infection occurred in seven (13·5%) patients. Interpretation The mortality of critically ill patients with SARS-CoV-2 pneumonia is considerable. The survival time of the non-survivors is likely to be within 1–2 weeks after ICU admission. Older patients (>65 years) with comorbidities and ARDS are at increased risk of death. The severity of SARS-CoV-2 pneumonia poses great strain on critical care resources in hospitals, especially if they are not adequately staffed or resourced. Funding None.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              First Case of 2019 Novel Coronavirus in the United States

              Summary An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clinical course, and management of the case, including the patient’s initial mild symptoms at presentation with progression to pneumonia on day 9 of illness. This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.
                Bookmark

                Author and article information

                Contributors
                Role: Professor
                Journal
                J Cardiothorac Vasc Anesth
                J. Cardiothorac. Vasc. Anesth
                Journal of Cardiothoracic and Vascular Anesthesia
                Elsevier Inc.
                1053-0770
                1532-8422
                7 April 2020
                7 April 2020
                Affiliations
                [0001]Cardiovascular and Thoracic Section, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
                Author notes
                [* ]Corresponding author: John G.T. Augoustides MD, FASE, FAHA, Professor, Cardiothoracic Section, Anesthesiology and Critical Care, Dulles 680, HUP, 3400 Spruce Street, Philadelphia, PA, 19104-4283, Tel: (215) 662-7631, Fax: (215) 349-8133 yiandoc@ 123456hotmail.com
                Article
                S1053-0770(20)30310-4
                10.1053/j.jvca.2020.03.060
                7141443
                32345529
                4df70302-4481-4dae-a3ae-8b3b040f38c8
                © 2020 Elsevier Inc. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Article

                extracorporeal membrane oxygenation,personnel,equipment,facilities,support systems

                Comments

                Comment on this article